At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AEMD Aethlon Medical
Trading 11-05 13:47:27 EST
5.36
-0.39
-6.78%
High5.72Low5.34Vol8.34K
Open5.72D1 Closing5.75Amplitude6.70%
Mkt Cap8.60MTradable Cap8.57MTotal Shares1.60M
T/O45.66KT/O Rate0.52%Tradable Shares1.60M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Aethlon Medical Grants Chief Medical Officer Steven LaRosa 42,000 Restricted Stock Units
Reuters  ·  10-16
Aethlon Medical Grants Chief Medical Officer Steven LaRosa 42,000 Restricted Stock Units
Aethlon Medical CEO Frakes Receives 42,000 RSUs Under 2020 Equity Incentive Plan
Reuters  ·  10-14
Aethlon Medical CEO Frakes Receives 42,000 RSUs Under 2020 Equity Incentive Plan
Aethlon Medical Expands Authorized Common Stock Capacity
TIPRANKS  ·  10-10
Aethlon Medical Expands Authorized Common Stock Capacity
Aethlon Medical Increases Authorized Common Shares to 200,000,000 from 20,000,000
Reuters  ·  10-10
Aethlon Medical Increases Authorized Common Shares to 200,000,000 from 20,000,000
Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares
Reuters  ·  10-06
Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares
Aethlon Medical Shareholders Expand Capital Structure Flexibility
TIPRANKS  ·  10-02
Aethlon Medical Shareholders Expand Capital Structure Flexibility
Aethlon Medical Holds Annual Shareholder Meeting
Reuters  ·  10-02
Aethlon Medical Holds Annual Shareholder Meeting
Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)
TIPRANKS  ·  09-24
Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
Benzinga Earnings  ·  09-17
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
Aethlon Medical Announces Merger with North Immunology
TIPRANKS  ·  09-17
Aethlon Medical Announces Merger with North Immunology
M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema
TIPRANKS  ·  09-17
M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema
U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical
Reuters  ·  09-17
U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical, North Immunology enter all-stock transaction
TIPRANKS  ·  09-17
Aethlon Medical, North Immunology enter all-stock transaction
Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology
THOMSON REUTERS  ·  09-17
Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology
Aethlon Medical Agrees All-Stock Merger with North Immunology
Reuters  ·  09-17
Aethlon Medical Agrees All-Stock Merger with North Immunology
Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co
THOMSON REUTERS  ·  09-17
Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co
Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology
THOMSON REUTERS  ·  09-17
Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology
Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln
THOMSON REUTERS  ·  09-17
Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln
Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company
THOMSON REUTERS  ·  09-17
Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company
Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028
THOMSON REUTERS  ·  09-17
Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028

Introduction

Company Name.
Aethlon Medical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Issue price:
--